type here...

Tag:#Pierre van Weperen

Medicinal Cannabis

Children’s Dutch Epilepsy Cannabis Medicines Will Be Made In The UK To Overcome Import Impasse

A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set to see the medicines made...
Peter -
Medicinal Cannabis

The UK Medical Cannabis Industry Can – And Does – Provide Epilepsy Medicines For Children In Post-Brexit Britain

Pierre Van Weperen of Grow Pharma on the post-Brexit issue surrounding the import of epilepsy cannabis medicines into the UK. MAINTAINING existing quality standards was...
Peter -
Comment

‘The Dutch Bedrocan Medicine Is The Only Viable Option For Treating Many Children’s Epilepsy’

Prof Mike Barnes, one of the UK's leading cannabis clinicians responds to suggestions that the medicines for UK children with epilepsy can be sourced...
Peter -
Comment

‘Failing’ Government Report Into Medicinal Cannabis Is A ‘Missed Opportunity’

The Advisory Council for the Misuse of Drugs' recent report on cannabis medicines is a missed opportunity, says Pierre Van Weperen of The Grow...
Peter -
Medicinal Cannabis

Huge Rise In UK Medical Cannabis Imports As Private Sector Steps-Up To Meet Patient Demand

NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling...
Peter -
Medicinal Cannabis

New Access Scheme Aims To Deliver Medical Cannabis To Thousands Of UK Patients

PATIENTS currently frozen out by an under-performing National Health Service are being offered access to cannabis medicine through a new private sector scheme. Around 700...
Peter -
Medicinal Cannabis

Grow Pharma Signs Partnership Deal With Australia’s Althea – Boosting UK Medical Cannabis Range by 20%

UK MEDICAL cannabis distributor Grow Pharma has boosted its patient product range by 20% after striking a new deal with Althea Group Holdings. Grow Pharma...
Peter -

Latest news

Press Releases

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and...
- Advertisement -spot_imgspot_img
Analysis

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...
Press Releases

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Must read

Editor Picks

Must Read

BusinessCann

About BusinessCann

BusinessCann delivers news, features, comment and analysis with the people and businesses forging Europe’s hemp, medicinal cannabis and CBD wellness sectors.

Advertise | Contact Us | Terms & Conditions | Privacy Policy | Disclaimer

Follow Us

© 2022 - BusinessCann.com. All Rights Reserved.